(Q62104874)

English

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131-I-TM-601 in Adult Patients With Recurrent High-Grade Glioma (English)

0 references

0 references

0 references

0 references

United States of America

0 references

start time

November 2004

0 references

end time

March 2009

0 references

number of participants

66

0 references

clinical trial phase

phase II clinical trial

0 references

research site

University of Alabama at Birmingham

0 references

Emory University

0 references

University of South Florida

0 references

University of Utah Health Care

0 references

Cedars-Sinai Medical Center

0 references

Florida Hospital Cancer Institute

0 references

Northwestern University

0 references

University of Chicago

0 references

Johns Hopkins University

0 references

Mercy Health

0 references

Columbia University Irving Medical Center

0 references

University of Washington

0 references

research subject recruitment status

unknown

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00114309

0 references

(Q62104874)

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)